Lindbrook Capital, LLC - HARMONY BIOSCIENCES HLDGS IN ownership

HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 205 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.7%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of HARMONY BIOSCIENCES HLDGS IN
ValueSharesWeighting
Q2 2023$387
-90.8%
11
-85.5%
0.00%
-100.0%
Q4 2022$4,188
-30.2%
76
-44.5%
0.00%0.0%
Q3 2022$6,000137
+2640.0%
0.00%
Q2 2022$050.00%
Other shareholders
HARMONY BIOSCIENCES HLDGS IN shareholders Q2 2023
NameSharesValueWeighting ↓
Valor Management LLC 11,218,033$394,762,58198.29%
venBio Partners LLC 1,035,396$36,435,58513.19%
Nan Fung Group Holdings Ltd 368,665$12,973,3218.29%
Vivo Capital, LLC 2,606,247$91,713,8326.33%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 570,500$20,070,1906.11%
Altium Capital Management LP 149,889$5,274,5943.99%
AlphaCentric Advisors LLC 118,000$4,152,4202.30%
ASHFORD CAPITAL MANAGEMENT INC 449,038$15,801,6472.21%
NEUMEIER POMA INVESTMENT COUNSEL LLC 636,240$22,389,2862.05%
TANG CAPITAL MANAGEMENT LLC 271,200$9,543,5281.40%
View complete list of HARMONY BIOSCIENCES HLDGS IN shareholders